Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infuse Open-Access Project A Model For The Future? Medtronic Thinks So

This article was originally published in The Pink Sheet Daily

Executive Summary

Two independent analyses published on Medtronic’s Infuse biologic bone graft do not paint a positive picture for the device, but they do represent an important model for the future of open-access data analysis for drugs and devices, both Medtronic and academic proponents say.

Advertisement

Related Content

INFUSE Review Leads To Discussion And Some Discord At NASS
No Advantage For Medtronic’s InFuse Versus Bone Graft In Spine Fusion
FDA Wants To Release “Masked” Marketing Application Data To Researchers
Data In The Raw: Yale Doc Hopes Medtronic Infuse Effort Will Spark Data Transparency Model
Medtronic Infuse Saga Prompts Questions About FDA Approval Process

Topics

Advertisement
UsernamePublicRestriction

Register

PS075869

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel